cbay share price forecast
The average CymaBay Therapeutics stock forecast from last 6 month is 90 and. Stock Price Forecast.
Oramed Pharmaceuticals Nasdaqcm Ormp Stock Price Quote Analysis Simply Wall St
The Score for CBAY is 31 which is 38 below its historic median score of 50 and infers higher risk than normal.
. The average price target is. The current CymaBay Therapeutics CBAY share price is 340. CBAY Stock Price Prediction 1000 19070 Upside Based on 5 Wall Street analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months.
According to 3 Wall Street analyst s that have issued a 1 year CBAY price target the average CBAY price target is 1067 with the highest CBAY stock price forecast at 1400 and the. Wainwright maintained a Buy rating on CymaBay Therapeutics CBAY Research Report with a price target of 1000. Markets US Stocks Health Technology.
The forecasts range from a low of 700 to a. During the last trading day the stock. Cymabay Therapeutics CBAY adaptive stock price forecast ideologically balanced news.
Were all about helping you get more from your money. Analyst Forecast According to 15 analysts the average rating for CBAY stock is Buy The 12-month stock price forecast is 102 which is an increase of 19651 from the. Given the current short-term trend the stock is expected to fall -1007 during the next 3 months and with a 90 probability hold a price between 285 and 351 at the end of.
Lets get started today. Close price at the end of the last trading day Wednesday 26th Oct 2022 of the CBAY stock was 341. Forecast for 2023 is 546 forecast for 2024 is 654 forecast for 2025 is 777 forecast for 2026 is 901.
The averaged price 90. See more on advanced chart. According to 15 stock analysts the average 12-month stock price forecast for CBAY stock is 102 which predicts an increase of 20493.
USD 334 004 121. Live Market News Strategy Education On-Demand Videos and More. Cymabay Therapeutics Naive Prediction Price Forecast For the 25th of October Given 90 days horizon the Naive Prediction forecasted value of Cymabay.
Featuring AI generated news summaries. The average CymaBay Therapeutics stock forecast from last 6 month is 90 and this show a -1818 decrease in average from the prior price target of the each prediction. Machine learning powered price prediction.
Based on short-term price targets offered by eight analysts the average price target for CymaBay Therapeutics Inc. In the beginning at 88. At the end of the month 90 A.
Stock Price Forecast The 9 analysts offering 12-month price forecasts for Cymabay Therapeutics Inc have a median target of 1000 with a high estimate of 1400 and a low estimate of 700. Shares will drop by -427and reach 370 per share by September 2 2022. Maximum 97 minimum 83.
Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years based on the EPS. CBAY Stock Forecast Price Target for 2023 TradingView. Check Out Our Upgraded Website Experience Today.
This is 0292 less than the trading day before Tuesday 25th Oct. According to our technical. In a report released today Ed Arce from HC.
Based On Fundamental Analysis. The current CymaBay Therapeutics CBAY share price is 340. According to our current CBAY stock forecast the value of CymaBay Therapeutics Inc.
Ad Our Strong Buys Double the SP. Ad Trade stocks bonds options ETFs and mutual funds all in one easy-to-manage account. CymaBay Therapeutics stock stood at 310999989509583 on 2022-03-31.
Commonwealth Bank Of Australia share price forecast for April 2023. Ad Market News Just Got Easier to Navigate.
Cymabay Therapeutics Inc Share Price Usd0 0001
10 Penny Stocks With Insider Buying This Month Trka Lab Sbfm Rwlk Ctso Dc Cbay Nrdy Cnce Hlbz R Pennystocks
Best Stocks With 1 000 Upside Potential Investment U
Cymabay Therapeutics Inc S Nasdaq Cbay Latest 12 Decline Adds To One Year Losses Institutional Investors May Consider Drastic Measures Simply Wall St News
Cymabay Therapeutics Inc Cbay Stock Price Quote News Stock Analysis
7 Stocks The Insiders Are Buying On Sale Ulta Cbay Gme Investorplace
7 Stocks The Insiders Are Buying On Sale Ulta Cbay Gme Investorplace
Cbay Cymabay Therapeutics Inc Cnnmoney Com
Cymabay Therapeutics Inc Cbay 微博股票
Cymabay Therapeutics Nasdaqgs Cbay Share Price News Analysis Simply Wall St
Here S Why Cymabay Therapeutics Is Collapsing Today The Motley Fool
2 Strong Buy Penny Stocks With Substantial Upside Potential Nasdaq
Oppenheimer These 3 Strong Buy Stocks Could Double If Not More
Pdsb Stock Forecast Price News Pds Biotechnology
Cbay Stock Price And Chart Nasdaq Cbay Tradingview
3 Stocks Tipranks Indicate May Have More Than 100 Upside By Andrew Martin Datadriveninvestor
Earnings Outlook For Cymabay Therapeutics Cymabay Therapeutics Nasdaq Cbay Benzinga
Cymabay Therapeutics Inc S Nasdaq Cbay Latest 12 Decline Adds To One Year Losses Institutional Investors May Consider Drastic Measures Simply Wall St News
Ipo Preview Metacrine Begins 100 Million U S Ipo Plan Ipos On Thestreet U S Ipo Research Opinion